The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Stanzione Daniel since 2006.
The trader's CIK number is 1221534.
At the time of the last reporting, Stanzione Daniel was the Director of Quest Diagnostics Inc. (stock ticker symbol DGX).
Also see all insider trading activities at Quest Diagnostics Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2016 | INAP | 70,000 | $138,650 | 0 | $0 | 0 | $0 |
| 2015 | INAP | 0 | $0 | 27,000 | $283,041 | 27,000 | $124,199 |
| 2011 | INAP | 5,000 | $26,250 | 0 | $0 | 0 | $0 |
| 2009 | INAP | 5,000 | $19,050 | 0 | $0 | 0 | $0 |
| 2007 | INAP | 9,000 | $110,925 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2017 | DGX | 0 | $0 | 44,703 | $4,830,702 | 44,703 | $2,567,912 |
| 2015 | DGX | 0 | $0 | 8,000 | $567,752 | 8,000 | $399,520 |
| 2014 | DGX | 0 | $0 | 30,000 | $1,672,380 | 30,000 | $1,374,960 |
| 2012 | DGX | 0 | $0 | 60,000 | $3,630,000 | 60,000 | $2,798,820 |
| 2011 | DGX | 0 | $0 | 20,000 | $1,178,320 | 20,000 | $590,520 |
| 2006 | DGX | 1,000 | $49,726 | 0 | $0 | 0 | $0 |
2. Quest Diagnostics Inc (DGX)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2016-09-14 | INAP | Buy | 50,000 | 1.93 | 96,450 |
| 2016-02-23 | INAP | Buy | 20,000 | 2.11 | 42,200 |
| 2015-04-15 | INAP | Sale | 27,000 | 10.48 | 283,041 |
| 2015-04-15 | INAP | Option Ex | 27,000 | 4.60 | 124,199 |
| 2011-08-05 | INAP | Buy | 5,000 | 5.25 | 26,250 |
| 2009-12-11 | INAP | Buy | 5,000 | 3.81 | 19,050 |
| 2007-11-30 | INAP | Buy | 4,000 | 10.00 | 40,000 |
| 2007-08-21 | INAP | Buy | 2,500 | 14.79 | 36,975 |
| 2007-06-13 | INAP | Buy | 2,500 | 13.58 | 33,950 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2017-09-11 | DGX | Sale | 40,900 | 108.07 | 4,419,940 |
| 2017-09-11 | DGX | Option Ex | 40,900 | 57.51 | 2,352,077 |
| 2017-09-05 | DGX | Option Ex | 3,803 | 56.75 | 215,835 |
| 2017-09-05 | DGX | Sale | 3,803 | 108.01 | 410,762 |
| 2015-02-11 | DGX | Option Ex | 8,000 | 49.94 | 399,520 |
| 2015-02-11 | DGX | Sale | 8,000 | 70.97 | 567,752 |
| 2014-04-30 | DGX | Sale | 30,000 | 55.75 | 1,672,380 |
| 2014-04-30 | DGX | Option Ex | 30,000 | 45.83 | 1,374,960 |
| 2012-07-12 | DGX | Option Ex | 30,000 | 42.93 | 1,287,840 |
| 2012-07-12 | DGX | Sale | 30,000 | 62.00 | 1,860,000 |
| 2012-01-27 | DGX | Option Ex | 30,000 | 50.37 | 1,510,980 |
| 2012-01-27 | DGX | Sale | 30,000 | 59.00 | 1,770,000 |
| 2011-02-07 | DGX | Sale | 20,000 | 58.92 | 1,178,320 |
| 2011-02-07 | DGX | Option Ex | 20,000 | 29.53 | 590,520 |
| 2006-10-26 | DGX | Buy | 1,000 | 49.73 | 49,726 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Stanzione Daniel (Director of Quest Diagnostics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.